Premium
Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long‐term left ventricular dysfunction and remodelling in systemic sclerosis: 7‐year follow‐up study
Author(s) -
Mizuno Reiko,
Fujimoto Shinichi,
Saito Yoshihiko,
Nakamura Shinobu
Publication year - 2010
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1093/eurjhf/hfp198
Subject(s) - medicine , cardiology , ejection fraction , provocation test , heart failure , prospective cohort study , cardiac dysfunction , pathology , alternative medicine
Aims The clinical importance of cold‐induced reversible myocardial ischaemia, known as cardiac Raynaud's phenomenon (C‐Raynaud), has not been established in systemic sclerosis (SSc). This prospective study investigated the impact of C‐Raynaud on long‐term irreversible left ventricular (LV) functional and morphologic deterioration in SSc. Methods and results Fifty‐one SSc patients with no clinical evidence of cardiac involvement were prospectively followed up for 7.1 ± 2.2 years. Systolic LV dysfunction was defined as a LV ejection fraction <50%. Left ventricular remodelling was defined as an increase in LV volume during follow‐up of more than 20% compared with baseline values. At the initial evaluation, C‐Raynaud was found in 15 patients (29.4%). Of these, eight patients had severe C‐Raynaud. None of the patients had systolic LV dysfunction. At the final evaluation, five patients had developed systolic LV dysfunction. In four of these five patients, the development of systolic LV dysfunction was associated with LV remodelling. At multivariate analysis, severe C‐Raynaud was a strong independent determinant of the development of long‐term systolic LV dysfunction. Conclusion This study documents for the first time that severe C‐Raynaud is a strong long‐term predictor of systolic LV dysfunction in SSc patients. Detection of C‐Raynaud is clinically important for identifying SSc patients at high risk of cardiac deterioration at latent stage.